An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapyLishuang Qi, Zheng Guo, Yang Li et al.|British Journal of Cancer|2016Cited by 50
An individualized gene expression signature for prediction of lung adenocarcinoma metastasesLishuang Qi, Zheng Guo, Xin Li et al.|Molecular Oncology|2017Cited by 47
Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinomaYing Li, Zheng Guo, Wenbin Jiang et al.|Journal of Translational Medicine|2020Cited by 21
A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant ChemotherapyYixin Liu, Lishuang Qi, Zheyang Zhang et al.|Frontiers in Oncology|2019Cited by 6
An Exon Signature to Estimate the Tumor Mutational Burden of Right-sided Colon Cancer PatientsWenbing Guo, Zheng Guo, Yelin Fu et al.|Journal of Cancer|2019Cited by 5